New drugs are improving survival times for patients with aggressive type of blood cancer
Survival times for a highly aggressive type of blood cancer have nearly doubled over the…
Browsing: Lymphoma
Modern blood cancer treatments require new approach for monitoring, reporting side effects
Treatment changes including the advent of targeted and immune therapies have dramatically improved survival for…
JAK inhibitors associated with aggressive lymphoma
Austrian researchers have discovered that a small number of patients taking targeted drugs known as…
Genomic analysis unravels complexities of the most common form of lymphoma and enables personalised treatment
The majority of patients with diffuse large B cell lymphoma (DLBCL) can be treated effectively.…
Many adolescent and young adult cancer survivors have more social connections than peers
Survivors of adolescent and young adult cancer often have stronger social networks than their non-cancer…
Breast cancer and lymphoma treatments save lives, but may make heart failure more likely for some
Patients with a history of breast cancer or lymphoma were more than three times as…
Deep sea creatures provide a guiding light in the quest to develop cancer therapies
A team of scientists at the Keck School of Medicine of USC is looking to…
Genetic link found between the immune system and lymphoma
People who inherit genetic changes which alter the function of their immune system are at…
For cancer patients with HIV, immunotherapy appears safe
A new category of immunotherapies called checkpoint inhibitors that has been highly effective against many…
‘Double decker’ antibody technology fights cancer
Scientists from The Scripps Research Institute (TSRI) have created a new class of antibody-drug conjugates…